Publications by authors named "Daniel Catovsky"

Claim this Profile
A
A 3-decade multicenter European experience with cladribine as upfront treatment in 384 patients with hairy cell leukemia.
Alessandro Broccoli, Lisa Argnani, Matthew Cross, Agnieszka Janus, Elsa Maitre, Daniel Catovsky

Blood Adv· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies.
Andrea G S Pepper, Antonella Zucchetto, Kevin Norris, Erika Tissino, Jerry Polesel, Daniel Catovsky

Leukemia· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between deaths from infection and mutations of the BRAF, FBXW7, NRAS and XPO1 genes: a report from the LRF CLL4 trial.
Monica Else, Stuart J Blakemore, Jonathan C Strefford, Daniel Catovsky

Leukemia· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early clinical trials in chronic lymphocytic leukaemia in the UK.
Daniel Catovsky, Monica Else

Br J Haematol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial.
Stuart J Blakemore, Ruth Clifford, Helen Parker, Pavlos Antoniou, Ewa Stec-Dziedzic, Daniel Catovsky

Leukemia· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics.
Helen E Speedy, Renée Beekman, Vicente Chapaprieta, Giulia Orlando, Philip J Law, Daniel Catovsky

Nat Commun· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials.
Tomasz K Wojdacz, Harindra E Amarasinghe, Latha Kadalayil, Alice Beattie, Jade Forster, Daniel Catovsky

Blood Adv· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology.
Molly Went, Amit Sud, Helen Speedy, Nicola J Sunter, Asta Försti, Daniel Catovsky

Blood Cancer J· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.
Michael Hallek, Bruce D Cheson, Daniel Catovsky, Federico Caligaris-Cappio, Guillermo Dighiero

Blood· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.
Michael R Grever, Omar Abdel-Wahab, Leslie A Andritsos, Versha Banerji, Jacqueline Barrientos, Daniel Catovsky

Blood· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.
Philip J Law, Sonja I Berndt, Helen E Speedy, Nicola J Camp, Georgina P Sava, Daniel Catovsky

Nat Commun· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.
Philip J Law, Amit Sud, Jonathan S Mitchell, Marc Henrion, Giulia Orlando, Daniel Catovsky

Sci Rep· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia.
Helen E Speedy, Ben Kinnersley, Daniel Chubb, Peter Broderick, Philip J Law, Daniel Catovsky

Blood· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of serum markers in the LRF CLL4 trial: β2-microglobulin but not serum free light chains, is an independent marker of overall survival.
Guy Pratt, Peter Thomas, Nicola Marden, Denis Alexander, Zadie Davis, Daniel Catovsky

Leuk Lymphoma· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial.
David Oscier, Monica Else, Estella Matutes, Ricardo Morilla, Jonathan C Strefford, Daniel Catovsky

Br J Haematol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Predisposition to Chronic Lymphocytic Leukemia Is Mediated by a BMF Super-Enhancer Polymorphism.
Radhika Kandaswamy, Georgina P Sava, Helen E Speedy, Sílvia Beà, José I Martín-Subero, Daniel Catovsky

Cell Rep· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The outcome of Chronic lymphocytic leukaemia patients with 97% IGHV gene identity to germline is distinct from cases with <97% identity and similar to those with 98% identity.
Zadie Davis, Francesco Forconi, Anton Parker, Anne Gardiner, Peter Thomas, Daniel Catovsky

Br J Haematol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer.
Nichola Johnson, Paolo De Ieso, Gabriele Migliorini, Nick Orr, Peter Broderick, Daniel Catovsky

Cancer Res· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The long-term outcome of patients in the LRF CLL4 trial: the effect of salvage treatment and biological markers in those surviving 10 years.
Monica Else, Rachel Wade, David Oscier, Daniel Catovsky

Br J Haematol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An unusual indication for splenectomy in hairy cell leukaemia: a report of three cases with persistent splenomegaly after chemoimmunotherapy.
Nadav Sarid, Humayun N Ahmad, Andrew Wotherspoon, Claire E Dearden, Monica Else, Daniel Catovsky

Br J Haematol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up after purine analogue therapy in hairy cell leukaemia.
Monica Else, Claire E Dearden, Daniel Catovsky

Best Pract Res Clin Haematol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical significance of patients' sex in chronic lymphocytic leukemia.
Daniel Catovsky, Rachel Wade, Monica Else

Haematologica· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial.
Matthew J J Rose-Zerilli, Jade Forster, Helen Parker, Anton Parker, Ana E Rodríguez, Daniel Catovsky

Haematologica· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.
Helen E Speedy, Maria Chiara Di Bernardo, Georgina P Sava, Martin J S Dyer, Amy Holroyd, Daniel Catovsky

Nat Genet· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemia.
Gillian G Johnson, Ke Lin, Trevor F Cox, Melanie Oates, David R Sibson, Daniel Catovsky

Blood· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis